CSPC Pharmaceutical Group logo

CSPC Pharmaceutical Group

Asia, Hebei, China, Shijiazhuang

Description

CSPC Pharmaceutical Group is a pharmaceutical group in China.

Investor Profile

CSPC Pharmaceutical Group has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CSPC Pharmaceutical Group frequently co-invest with?

CICC
Asia, Beijing, China, Beijing
Co-Investments: 1
3H Health Investment
Asia, Hong Kong Island, Hong Kong, Cyberport
Co-Investments: 1
ALAN AMC
Asia, Beijing, China, Beijing
Co-Investments: 1
Legend Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Atlas Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 1
Chaos Investment
Asia, Shanghai, China, Shanghai
Co-Investments: 1
BioTrack Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 2
CMB International Capital Corporation
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1
Shanghai STVC Group
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Yingke Capital
Asia, Jiangxi, China, Fuzhou
Co-Investments: 2

What are some of recent deals done by CSPC Pharmaceutical Group?

Haihe Biopharma

Shanghai, Shanghai, China

Haihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BJul 24, 2020
Amount Raised: $171,005,942
Haihe Biopharma

Shanghai, Shanghai, China

Haihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Series BFeb 11, 2019
Amount Raised: $146,600,000